200 related articles for article (PubMed ID: 33995277)
41. Accuracy of adrenal imaging and adrenal venous sampling in diagnosing unilateral primary aldosteronism.
Ladurner R; Sommerey S; Buechner S; Dietz A; Degenhart C; Hallfeldt K; Gallwas J
Eur J Clin Invest; 2017 May; 47(5):372-377. PubMed ID: 28299775
[TBL] [Abstract][Full Text] [Related]
42. Targeted Molecular Characterization of Aldosterone-Producing Adenomas in White Americans.
Nanba K; Omata K; Else T; Beck PCC; Nanba AT; Turcu AF; Miller BS; Giordano TJ; Tomlins SA; Rainey WE
J Clin Endocrinol Metab; 2018 Oct; 103(10):3869-3876. PubMed ID: 30085035
[TBL] [Abstract][Full Text] [Related]
43. Urine steroid metabolomics as a diagnostic tool in primary aldosteronism.
Prete A; Lang K; Pavlov D; Rhayem Y; Sitch AJ; Franke AS; Gilligan LC; Shackleton CHL; Hahner S; Quinkler M; Dekkers T; Deinum J; Reincke M; Beuschlein F; Biehl M; Arlt W
J Steroid Biochem Mol Biol; 2024 Mar; 237():106445. PubMed ID: 38104729
[TBL] [Abstract][Full Text] [Related]
44. Somatic KCNJ5 mutation occurring early in adrenal development may cause a novel form of juvenile primary aldosteronism.
Tamura A; Nishimoto K; Seki T; Matsuzawa Y; Saito J; Omura M; Gomez-Sanchez CE; Makita K; Matsui S; Moriya N; Inoue A; Nagata M; Sasano H; Nakamura Y; Yamazaki Y; Kabe Y; Mukai K; Kosaka T; Oya M; Suematsu S; Nishikawa T
Mol Cell Endocrinol; 2017 Feb; 441():134-139. PubMed ID: 27514282
[TBL] [Abstract][Full Text] [Related]
45. Interference by spironolactone on adrenocortical scintigraphy and other pitfalls in the location of adrenal abnormalities in primary aldosteronism.
Shapiro B; Grekin R; Gross MD; Freitas JE
Clin Nucl Med; 1994 May; 19(5):441-5. PubMed ID: 8039321
[TBL] [Abstract][Full Text] [Related]
46. Role for germline mutations and a rare coding single nucleotide polymorphism within the KCNJ5 potassium channel in a large cohort of sporadic cases of primary aldosteronism.
Murthy M; Xu S; Massimo G; Wolley M; Gordon RD; Stowasser M; O'Shaughnessy KM
Hypertension; 2014 Apr; 63(4):783-9. PubMed ID: 24420545
[TBL] [Abstract][Full Text] [Related]
47. Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism.
Boulkroun S; Beuschlein F; Rossi GP; Golib-Dzib JF; Fischer E; Amar L; Mulatero P; Samson-Couterie B; Hahner S; Quinkler M; Fallo F; Letizia C; Allolio B; Ceolotto G; Cicala MV; Lang K; Lefebvre H; Lenzini L; Maniero C; Monticone S; Perrocheau M; Pilon C; Plouin PF; Rayes N; Seccia TM; Veglio F; Williams TA; Zinnamosca L; Mantero F; Benecke A; Jeunemaitre X; Reincke M; Zennaro MC
Hypertension; 2012 Mar; 59(3):592-8. PubMed ID: 22275527
[TBL] [Abstract][Full Text] [Related]
48. Novel somatic mutations in primary hyperaldosteronism are related to the clinical, radiological and pathological phenotype.
Scholl UI; Healy JM; Thiel A; Fonseca AL; Brown TC; Kunstman JW; Horne MJ; Dietrich D; Riemer J; Kücükköylü S; Reimer EN; Reis AC; Goh G; Kristiansen G; Mahajan A; Korah R; Lifton RP; Prasad ML; Carling T
Clin Endocrinol (Oxf); 2015 Dec; 83(6):779-89. PubMed ID: 26252618
[TBL] [Abstract][Full Text] [Related]
49. Primary aldosteronism concurrent with subclinical Cushing's syndrome: a case report and review of the literature.
Zhang Y; Tan J; Yang Q; Du Z; Yang S; He W; Song Y; Hu J; Yang Y; Li Q; Zhang Y; He Y; Cheng Q;
J Med Case Rep; 2020 Feb; 14(1):32. PubMed ID: 32075693
[TBL] [Abstract][Full Text] [Related]
50. Scintigraphy of incidentally discovered bilateral adrenal masses.
Gross MD; Shapiro B; Francis IR; Bree RL; Korobkin M; McLeod MK; Thompson NW; Sanfield JA
Eur J Nucl Med; 1995 Apr; 22(4):315-21. PubMed ID: 7607261
[TBL] [Abstract][Full Text] [Related]
51. Aldosterone-producing adenoma-harbouring KCNJ5 mutations is associated with lower prevalence of metabolic disorders and abdominal obesity.
Chen KM; Chang YL; Wu TH; Lee BC; Chen PT; Liu KL; Hong JS; Chang CC; Wu VC; Lin YH;
J Hypertens; 2021 Dec; 39(12):2353-2360. PubMed ID: 34313632
[TBL] [Abstract][Full Text] [Related]
52. 18-Oxocortisol Synthesis in Aldosterone-Producing Adrenocortical Adenoma and Significance of KCNJ5 Mutation Status.
Tezuka Y; Yamazaki Y; Kitada M; Morimoto R; Kudo M; Seiji K; Takase K; Kawasaki Y; Mitsuzuka K; Ito A; Nishikawa J; Asai N; Nakamura Y; Gomez-Sanchez CE; Ito S; Dezawa M; Sasano H; Satoh F
Hypertension; 2019 Jun; 73(6):1283-1290. PubMed ID: 31006333
[TBL] [Abstract][Full Text] [Related]
53. Presence of Subclinical Hypercortisolism in Clinical Aldosterone-Producing Adenomas Predicts Lower Clinical Success.
Peng KY; Liao HW; Chan CK; Lin WC; Yang SY; Tsai YC; Huang KH; Lin YH; Chueh JS; Wu VC
Hypertension; 2020 Nov; 76(5):1537-1544. PubMed ID: 32921192
[TBL] [Abstract][Full Text] [Related]
54. Adrenocortical SPECT using iodine-131 NP-59.
Hwang I; Balingit AG; Georgitis WJ; Sisson JC; Shapiro B
J Nucl Med; 1998 Aug; 39(8):1460-3. PubMed ID: 9708530
[TBL] [Abstract][Full Text] [Related]
55. Novel somatic mutations and distinct molecular signature in aldosterone-producing adenomas.
Åkerström T; Willenberg HS; Cupisti K; Ip J; Backman S; Moser A; Maharjan R; Robinson B; Iwen KA; Dralle H; D Volpe C; Bäckdahl M; Botling J; Stålberg P; Westin G; Walz MK; Lehnert H; Sidhu S; Zedenius J; Björklund P; Hellman P
Endocr Relat Cancer; 2015 Oct; 22(5):735-44. PubMed ID: 26285814
[TBL] [Abstract][Full Text] [Related]
56. Iodomethylnorcholesterol uptake in an aldosteronoma shown by dexamethasone-suppression scintigraphy: relationship to adenoma size and functional activity.
Nomura K; Kusakabe K; Maki M; Ito Y; Aiba M; Demura H
J Clin Endocrinol Metab; 1990 Oct; 71(4):825-30. PubMed ID: 2401712
[TBL] [Abstract][Full Text] [Related]
57. Aldosterone Suppression by Dexamethasone in Patients With KCNJ5-Mutated Aldosterone-Producing Adenoma.
Inoue K; Yamazaki Y; Kitamoto T; Hirose R; Saito J; Omura M; Sasano H; Nishikawa T
J Clin Endocrinol Metab; 2018 Sep; 103(9):3477-3485. PubMed ID: 30020487
[TBL] [Abstract][Full Text] [Related]
58. The role of adrenal scintigraphy in the preoperative management of primary aldosteronism.
Volpe C; Enberg U; Sjögren A; Wahrenberg H; Jacobsson H; Törring O; Hamberger B; Thorén M
Scand J Surg; 2008; 97(3):248-53. PubMed ID: 18812275
[TBL] [Abstract][Full Text] [Related]
59. 131I-6beta-iodomethyl-19-norcholesterol SPECT/CT for primary aldosteronism patients with inconclusive adrenal venous sampling and CT results.
Yen RF; Wu VC; Liu KL; Cheng MF; Wu YW; Chueh SC; Lin WC; Wu KD; Tzen KY; Lu CC;
J Nucl Med; 2009 Oct; 50(10):1631-7. PubMed ID: 19759122
[TBL] [Abstract][Full Text] [Related]
60. Hormonal, Radiological, NP-59 Scintigraphy, and Pathological Correlations in Patients With Cushing's Syndrome Due to Primary Pigmented Nodular Adrenocortical Disease (PPNAD).
Vezzosi D; Tenenbaum F; Cazabat L; Tissier F; Bienvenu M; Carrasco CA; Laloi-Michelin M; Barrande G; Lefebvre H; Hiéronimus S; Tabarin A; Bertagna X; Legmann P; Vantyghem MC; Bertherat J
J Clin Endocrinol Metab; 2015 Nov; 100(11):4332-8. PubMed ID: 26390100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
